Sort by:

select Language:

Landscape for HIV rapid diagnostic tests for HIV self-testing

World Health Organization WHO; UNITAID, (2018)

This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United Nation’s 90-90-90 targets. In particular, the report synthesises the existing and emerging market demand and supply of kits. The information in this report is intended for manufacturers, donors, national programmes, researchers and other global health stakeholders who are exploring the potential role of HIVST.

Technology and Market Landscape Hepatitis C Medicines, August 2017

A.Hill, T. Swan and K.Timmermans , Eds.: World Health Organisation (WHO); UNITAID, (2017)

Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi- nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim- ited. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low- income countries alike. Now there is a divide between those countries where, because of intellectual property barriers, prices have remained (very) high and other countries where generics are, or can be, available at much lower prices. The result is a dual market

Laboratory testing for Middle East Respiratory Syndrome Coronavirus

World Health Organization WHO, (2015)

The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).

HIV/AIDS Diagnostics Technology Landscape

UNITAID Secretariat, World Health Organization, (2015)

Semi-annual Update

Specifications and quantities for efficient procurement of essential equipment and laboratory commodities for HIV

Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al., Eds.: World Health Organization, (2015)

Second Edition AIDS Medicines and diagnostics services July 2015

Zika virus (ZIKV) Surveillance in the Americas: Laboratory detection and diagnosis

Pan American Health Organization PAHO; World Health Organization, Regional Office for the Americas, (2016)

This algorithm is addressed to laboratories with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.

Vigilancia del virus Zika (ZIKV) en las Américas: Detección y diagnóstico por laboratorio

Organización Panamericana de la Salud/ Organización Mundial de la Salud, Oficina Regional para las Américas, (2016)

Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sospechosas, se requiere un nivel de contención BSL2

13 hits